ENANTA PHARMACEUTICALS INC
43 SEC EDGAR filings indexed (CIK 0001177648) across 9 form types.
Filing profile
ENANTA PHARMACEUTICALS INC (ENTA) has 43 SEC filings indexed on SecFilingDex, across 9 form types filed over roughly 3 years, from January 26, 2024 to August 12, 2026. The filer is classified under Pharmaceutical Preparations (SIC 2834).
Its most frequent disclosure is the 10-Q (Quarterly report) with 8 filings — Unaudited quarterly financial report filed by U.S. public companies for the first three fiscal quarters. 28 of these filings were disclosed in the twelve months to August 12, 2026. 5 of the 43 are amendments (a corrected or updated version of an earlier filing).
Disclosure mix
- 810-QQuarterly report · quarterly
- 88-KMaterial event · event-driven
- 8Form 4Insider transaction · within 2 business days of transaction
- 5SC 13G/A5%+ passive stake · event-driven
- 3424B5Prospectus supplement · event-driven
- 3DEF 14AProxy statement · annual (pre-meeting)
- 3DEFA14ASEC filing
- 3Form 3Initial insider ownership · within 10 days of becoming an insider
- 210-KAnnual report · annual
Profile derived from 43 indexed filings; every figure traces to the filing records above, each linking back to its original SEC EDGAR document. Filing counts reflect SecFilingDex's current index, not the filer's complete EDGAR history.
All filings
- 10-QQuarterly report · period of report Jun 30, 2026Filed · 0001193125-26-345719
- 8-KMaterial event · period of report Aug 10, 2026Filed · 0001193125-26-342336
- Form 4Insider transaction · period of report Aug 8, 2026Filed · 0002064832-26-000266
- 424B5Prospectus supplementFiled · 0001193125-26-294828
- 8-KMaterial event · period of report Jul 2, 2026Filed · 0001193125-26-294837
- 8-KMaterial event · period of report Jun 23, 2026Filed · 0001193125-26-279803
- 8-KMaterial event · period of report Jun 18, 2026Filed · 0001193125-26-274950
- 10-QQuarterly report · period of report Mar 31, 2026Filed · 0001193125-26-220572
- 8-KMaterial event · period of report May 11, 2026Filed · 0001193125-26-216735
- 8-KMaterial event · period of report Mar 20, 2026Filed · 0001193125-26-125113
- Form 4Insider transaction · period of report Mar 11, 2026Filed · 0002064832-26-000138
- Form 4Insider transaction · period of report Mar 11, 2026Filed · 0002064832-26-000139
- Form 4Insider transaction · period of report Mar 11, 2026Filed · 0002064832-26-000140
- Form 4Insider transaction · period of report Mar 11, 2026Filed · 0002064832-26-000141
- Form 4Insider transaction · period of report Mar 11, 2026Filed · 0002064832-26-000142
- Form 4Insider transaction · period of report Mar 11, 2026Filed · 0002064832-26-000143
- 8-KMaterial event · period of report Mar 11, 2026Filed · 0001193125-26-104109
- Form 4Insider transaction · period of report Feb 12, 2026Filed · 0002064832-26-000016
- 10-QQuarterly report · period of report Dec 31, 2025Filed · 0001193125-26-046502
- 8-KMaterial event · period of report Feb 9, 2026Filed · 0001193125-26-042812
- DEF 14AProxy statement · period of report Mar 11, 2026Filed · 0001193125-26-022558
- DEFA14ASEC filingFiled · 0001193125-26-022585
- 10-KAnnual report · period of report Sep 30, 2025Filed · 0001193125-25-288121
- 424B5Prospectus supplementFiled · 0001193125-25-226794
- 424B5Prospectus supplementFiled · 0001193125-25-225149
- Form 3Initial insider ownership · period of report Aug 26, 2025Filed · 0001062993-25-015414
- Form 3Initial insider ownership · period of report Aug 26, 2025Filed · 0001062993-25-015415
- 10-QQuarterly report · period of report Jun 30, 2025Filed · 0001193125-25-179795
- 10-QQuarterly report · period of report Mar 31, 2025Filed · 0000950170-25-071340
- 10-QQuarterly report · period of report Dec 31, 2024Filed · 0000950170-25-018810
- DEF 14AProxy statement · period of report Mar 13, 2025Filed · 0000950170-25-009168
- DEFA14ASEC filingFiled · 0001193125-25-013325
- 10-KAnnual report · period of report Sep 30, 2024Filed · 0000950170-24-131260
- SC 13G/A5%+ passive stakeFiled · 0001172661-24-005156
- SC 13G/A5%+ passive stakeFiled · 0001273087-24-000102
- 10-QQuarterly report · period of report Jun 30, 2024Filed · 0000950170-24-092714
- 10-QQuarterly report · period of report Mar 31, 2024Filed · 0000950170-24-055581
- Form 3Initial insider ownership · period of report Apr 29, 2024Filed · 0001062993-24-009173
- SC 13G/A5%+ passive stakeFiled · 0001172661-24-001225
- SC 13G/A5%+ passive stakeFiled · 0001104659-24-020838
- SC 13G/A5%+ passive stakeFiled · 0000908834-24-000024
- DEF 14AProxy statement · period of report Mar 6, 2024Filed · 0000950170-24-007956
- DEFA14ASEC filingFiled · 0001193125-24-016774
Authoritative source
SecFilingDex republishes EDGAR data with provenance. EDGAR is authoritative; this page reflects the most recent index pull.
Disclaimer: SecFilingDex is independent and not affiliated with the U.S. Securities and Exchange Commission. Nothing on this page is investment, legal, or tax advice.